469 related articles for article (PubMed ID: 29317252)
41. Enteroendocrine cells in gastrointestinal pathophysiology.
Harrison E; Lal S; McLaughlin JT
Curr Opin Pharmacol; 2013 Dec; 13(6):941-5. PubMed ID: 24206752
[TBL] [Abstract][Full Text] [Related]
42. Molecular mechanistic pathway of colorectal carcinogenesis associated with intestinal microbiota.
Mandal P
Anaerobe; 2018 Feb; 49():63-70. PubMed ID: 29277623
[TBL] [Abstract][Full Text] [Related]
43. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.
Kirpich IA; Marsano LS; McClain CJ
Clin Biochem; 2015 Sep; 48(13-14):923-30. PubMed ID: 26151226
[TBL] [Abstract][Full Text] [Related]
44. High-Salt Diet Gets Involved in Gastrointestinal Diseases through the Reshaping of Gastroenterological Milieu.
Li J; Sun F; Guo Y; Fan H
Digestion; 2019; 99(4):267-274. PubMed ID: 30293081
[TBL] [Abstract][Full Text] [Related]
45. Growing GI cells may lead to personalised treatments.
Sci Prog; 2014; 97(Pt 3):292. PubMed ID: 25549416
[No Abstract] [Full Text] [Related]
46. Unique roles in health promotion of dietary flavonoids through gut microbiota regulation: Current understanding and future perspectives.
Li Z; Ren Z; Zhao L; Chen L; Yu Y; Wang D; Mao X; Cao G; Zhao Z; Yang H
Food Chem; 2023 Jan; 399():133959. PubMed ID: 36001928
[TBL] [Abstract][Full Text] [Related]
47. The dynamic distribution of porcine microbiota across different ages and gastrointestinal tract segments.
Zhao W; Wang Y; Liu S; Huang J; Zhai Z; He C; Ding J; Wang J; Wang H; Fan W; Zhao J; Meng H
PLoS One; 2015; 10(2):e0117441. PubMed ID: 25688558
[TBL] [Abstract][Full Text] [Related]
48. The rich pharmacological activities of Magnolia officinalis and secondary effects based on significant intestinal contributions.
Niu L; Hou Y; Jiang M; Bai G
J Ethnopharmacol; 2021 Dec; 281():114524. PubMed ID: 34400262
[TBL] [Abstract][Full Text] [Related]
49. Probiotics and gastrointestinal conditions: An overview of evidence from the Cochrane Collaboration.
Parker EA; Roy T; D'Adamo CR; Wieland LS
Nutrition; 2018 Jan; 45():125-134.e11. PubMed ID: 28870406
[TBL] [Abstract][Full Text] [Related]
50. Age-dependent changes in GI physiology and microbiota: time to reconsider?
An R; Wilms E; Masclee AAM; Smidt H; Zoetendal EG; Jonkers D
Gut; 2018 Dec; 67(12):2213-2222. PubMed ID: 30194220
[TBL] [Abstract][Full Text] [Related]
51. Proanthocyanidins at the gastrointestinal tract: mechanisms involved in their capacity to mitigate obesity-associated metabolic disorders.
Zhu W; Oteiza PI
Crit Rev Food Sci Nutr; 2024; 64(2):220-240. PubMed ID: 35943169
[TBL] [Abstract][Full Text] [Related]
52. Homeostasis of the gut barrier and potential biomarkers.
Wells JM; Brummer RJ; Derrien M; MacDonald TT; Troost F; Cani PD; Theodorou V; Dekker J; Méheust A; de Vos WM; Mercenier A; Nauta A; Garcia-Rodenas CL
Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G171-G193. PubMed ID: 27908847
[TBL] [Abstract][Full Text] [Related]
53. Maintenance of Gastrointestinal Glucose Homeostasis by the Gut-Brain Axis.
Chen X; Eslamfam S; Fang L; Qiao S; Ma X
Curr Protein Pept Sci; 2017; 18(6):541-547. PubMed ID: 27356933
[TBL] [Abstract][Full Text] [Related]
54. Interactions between Bitter Taste, Diet and Dysbiosis: Consequences for Appetite and Obesity.
Turner A; Veysey M; Keely S; Scarlett C; Lucock M; Beckett EL
Nutrients; 2018 Sep; 10(10):. PubMed ID: 30241292
[TBL] [Abstract][Full Text] [Related]
55. Gut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health?
Belcheva A; Irrazabal T; Martin A
Bioessays; 2015 Apr; 37(4):403-12. PubMed ID: 25601287
[TBL] [Abstract][Full Text] [Related]
56. The Gastrointestinal Tract: an Initial Organ of Metabolic Hypertension?
Zhu Z; Xiong S; Liu D
Cell Physiol Biochem; 2016; 38(5):1681-94. PubMed ID: 27160520
[TBL] [Abstract][Full Text] [Related]
57. Microbiota and HDL metabolism.
Nakaya K; Ikewaki K
Curr Opin Lipidol; 2018 Feb; 29(1):18-23. PubMed ID: 29135690
[TBL] [Abstract][Full Text] [Related]
58. Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease.
Esgalhado M; Kemp JA; Damasceno NR; Fouque D; Mafra D
Future Microbiol; 2017 Nov; 12():1413-1425. PubMed ID: 29027814
[TBL] [Abstract][Full Text] [Related]
59. Involvement of gut microbiota in the association between gastrointestinal motility and 5‑HT expression/M2 macrophage abundance in the gastrointestinal tract.
Yang M; Fukui H; Eda H; Kitayama Y; Hara K; Kodani M; Tomita T; Oshima T; Watari J; Miwa H
Mol Med Rep; 2017 Sep; 16(3):3482-3488. PubMed ID: 28714029
[TBL] [Abstract][Full Text] [Related]
60. The Role of the Gastrointestinal Microbiota in Visceral Pain.
Rea K; O'Mahony SM; Dinan TG; Cryan JF
Handb Exp Pharmacol; 2017; 239():269-287. PubMed ID: 28035535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
